Join Women in Bio's RTP Chapter on December 10 for its End-of-Year Celebration—a special evening for women to connect, celebrate achievements, and enjoy meaningful networking. Additionally, Pepper ...

Tune Therapeutics, an epigenome-editing company based in Durham and Seattle, will be the first to initiate a human clinical trial for an epigenetic therapy for a common infectious disease.

This summit brings together international leaders from contract research organisations and functional service providers that support them for two days of discussion at the forefront of industry ...

In this interactive workshop, designed for small business owners and managers, you’ll discover key drivers of employee engagement, learn cost-effective strategies, and create a personalized engagement ...

Atlantic Fish, an emerging Raleigh company developing cultivated seafood, has received a $50,000 SEED grant from North ...

If you’re a visionary leader at a growth stage biopharma company, I help you identify a calculated and informed path to scale — one that mitigates risk, maximizes value, and capitalizes on your ...

The Conference Center at NCBiotech will be closed on Nov. 27, 2024. Also, NCBiotech's offices will be closed on Nov. 28-29, 2024, for the Thanksgiving holiday.

In RTP and need a place to plug in? Claim an office for the day, meet with clients, catch up with your team, use our market research reports, or just read this week's news and Business Journals.

To submit a proposal to one of NCBiotech’s funding programs, the Principal Investigator/Project Lead for the proposal must first register for an account on our Funding Portal. Go to the NCBiotech ...

Our state is home to a broad range of natural resources and scientific knowledge that, when combined, can transform communities from Manteo to Murphy. To bring that vision to reality, we opened our ...

Durham-based CytexOrtho, a company working to advance orthopedic joint preservation, has received approval from the U.S. Food and Drug Administration (FDA) to begin a first-in-human clinical study to ...